undamentalytics Newsletter

Definitive Healthcare Corp. income statement

In fiscal 2025, Definitive Healthcare Corp. reported revenue of $242m, down 4.2% on the year before, operating income of −$224m (a -92.9% margin) and net income of −$139m, or −$1.30 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Definitive Healthcare Corp.: income statement, annual
Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue118166223251252242233
Cost of revenue——4347555858
Gross profit88125180204197183175
Research and development11193542373531
Selling and marketing34569095848279
General and administrative14335259495250
Operating income−16−27−44−330−711−224−243
Interest expense36261115151111
Income before tax−53−63−42−308−634−209−238
Income tax0−0−18−19−42−10−3
Net income0−18−7−202−413−139−168
Diluted EPS—−$0.19−$0.07−$1.79−$3.54−$1.30−$1.61
Diluted shares (average)—92m101m113m117m107m104m
EBITDA−15−26−42−328−709−221−224

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AMWL vs DHDH vs HCATDH vs HSTM

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Definitive Healthcare Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Definitive Healthcare Corp.